(19)
(11) EP 1 471 443 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
published in accordance with Art. 158(3) EPC

(48) Corrigendum issued on:
26.01.2005 Bulletin 2005/04

(43) Date of publication:
27.10.2004 Bulletin 2004/44

(21) Application number: 03700474.4

(22) Date of filing: 08.01.2003
(51) International Patent Classification (IPC)7G06F 17/30, C07K 1/00
(86) International application number:
PCT/JP2003/000057
(87) International publication number:
WO 2003/060765 (24.07.2003 Gazette 2003/30)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 09.01.2002 JP 2002002859

(71) Applicant: Umeyama, Hideaki
Urayasu-shi, Chiba 279-0011 (JP)

(72) Inventors:
  • UMEYAMA, Hideaki
    Urayasu-shi, Chiba 279-0011 (JP)
  • IWADATE, Mitsuo
    Hanyu-shi, Saitama 348-0062 (JP)
  • SUZUKI, Eiichiro
    Sagamihara-shi, Kanagawa 228-0827 (JP)

(74) Representative: Clegg, Richard Ian 
Mewburn Ellis LLP York House 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) METHOD OF CONSTRUCTING STEREOSTRUCTURE OF PROTEIN HAVING PLURAL NUMBER OF CHAINS


(57) A method is provided of constructing a tertiary structure of a protein composed of plural chains having given arbitrary amino acid sequences by extending an comparative modeling method of constructing a tertiary structure of a protein composed of a single chain having a given arbitrary amino acid sequence (extended modeling method). In this method, an input file format of the plural chains in a computer software program is each corrected so as to present a form of a temporary single chain (correction of sequence alignment) and the tertiary structure is constructed based on the modeling method while assuming that the structure has plural chains in calculation of a potential formula by the computer software program, thereby constructing the tertiary structure of the target protein.
Namely, a method is provided of constructing the tertiary structure of an arbitrary protein having plural chains, which serves as a particularly important key factor in developing drugs or the like, highly accurately and much more efficiently than by a conventional method.